Comparison between Dar Credit IPO and Sheel Biotech IPO.
Dar Credit IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Sheel Biotech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Dar Credit IPO | Sheel Biotech IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Narnolia Financial Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | SMC Global Securities Ltd. | Mansi Share & Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dar Credit IPO is up to ₹24.36 Cr whereas the issue size of the Sheel Biotech IPO is up to ₹32.31 Cr. The final issue price of Dar Credit IPO is ₹60.00 per share and of Sheel Biotech IPO is ₹63.00 per share.
| Dar Credit IPO | Sheel Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹57.00 per share | ₹59.00 per share |
| Issue Price (Upper) | ₹60.00 per share | ₹63.00 per share |
| Issue Price (Final) | ₹60.00 per share | ₹63.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 2000 shares |
| Fresh Issue Size | 40,60,000 shares | 51,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹24.36 Cr | up to ₹32.31 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 40,60,000 shares | 51,28,000 shares |
| Issue Size Total (Amount) | up to ₹24.36 Cr | up to ₹32.31 Cr |
Dar Credit IPO opens on May 21, 2025, while Sheel Biotech IPO opens on Sep 30, 2025. The closing date of Dar Credit IPO and Sheel Biotech IPO is May 23, 2025, and Oct 03, 2025, respectively.
| Dar Credit IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Bid Date | May 20, 2025 | Sep 29, 2025 |
| Issue Open | May 21, 2025 | Sep 30, 2025 |
| Issue Close | May 23, 2025 | Oct 03, 2025 |
| Basis Of Allotment (Tentative) | May 26, 2025 | Oct 06, 2025 |
| Initiation of Refunds (Tentative) | May 27, 2025 | Oct 07, 2025 |
| Credit of Share (Tentative) | May 27, 2025 | Oct 07, 2025 |
| Listing date (Tentative) | May 28, 2025 | Oct 08, 2025 |
| Anchor Lockin End date 1 | Jun 25, 2025 | Nov 05, 2025 |
| Anchor Lockin End date 2 | Aug 24, 2025 | Jan 04, 2026 |
Dar Credit IPO P/E ratio is 15.12, as compared to Sheel Biotech IPO P/E ratio of 8.86.
| Dar Credit IPO | Sheel Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Standalone)
| Company Financials (Restated)Sheel Biotech Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 2% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98.47 | 96.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.98 | 71.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 15.12 | 8.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹85.66 Cr. | ₹128.22 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 6.17 | 13.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 9.22 | 16.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.51 | 0.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.97 | ₹7.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 6.08 | 13.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dar Credit IPO Retail Individual Investors (RII) are offered 14,22,000 shares while in Sheel Biotech IPO retail investors are offered 14,22,000 shares. Qualified Institutional Buyers (QIB) are offered 8,12,000 shares in Dar Credit IPO and 10,26,000 shares in Sheel Biotech IPO.
| Dar Credit IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 12,16,000 shares | 15,24,000 shares |
| Market Maker Reservation | 2,16,000 shares | 2,72,000 shares |
| QIB | 8,12,000 shares | 10,26,000 shares |
| NII | 6,10,000 shares | 7,74,000 shares |
| RII | 14,22,000 shares | 18,04,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 40,60,000 shares | 51,28,000 shares |
Dar Credit IPO subscribed 106.09x in total, whereas Sheel Biotech IPO subscribed 15.97x.
| Dar Credit IPO | Sheel Biotech IPO | |
|---|---|---|
| QIB (times) | 31.29x | 19.73x |
| NII (times) | 208.45x | 25.92x |
| Big NII (times) | 31.64x | |
| Small NII (times) | 14.49x | |
| RII (times) | 104.88x | 9.56x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 106.09x | 15.97x |
